{{ .infobox .infobox-gene }}
Il12A Gene Interleukin 12 Alpha is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
IL12A encodes the p35 subunit of interleukin-12 (IL-12), a heterodimeric cytokine that plays critical roles in bridging innate and adaptive immunity. IL-12 is essential for T helper 1 (Th1) cell differentiation and cell-mediated immunity. In the nervous system, IL-12 signaling contributes to neuroinflammation, a key feature of neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and multiple sclerosis[1].
IL-12 (p70) is composed of two subunits:
IL-12 binds to the IL-12 receptor (IL12RB1/IL12RB2):
IL-12/IL-23 signaling is elevated in AD:
IL-12 involvement in PD:
IL-12 is a key cytokine in MS:
Several therapies target the IL-12 pathway:
IL12A expression is primarily in immune cells:
IL12A is regulated at multiple levels:
Il12a knockout mice (p35-/-):
IL12A polymorphisms:
IL-12 as a biomarker:
IL12A encodes the p35 subunit of IL-12, a key cytokine linking innate and adaptive immunity. While primarily studied in immune contexts, its role in neuroinflammation makes it relevant to neurodegenerative diseases. Therapeutic modulation requires careful consideration of the balance between reducing harmful inflammation and maintaining protective immune function.
The study of Il12A Gene Interleukin 12 Alpha has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.